Citius Oncology, Inc. (CTOR)
CTOR Stock Price Chart
Explore Citius Oncology, Inc. interactive price chart. Choose custom timeframes to analyze CTOR price movements and trends.
CTOR Company Profile
Discover essential business fundamentals and corporate details for Citius Oncology, Inc. (CTOR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
8 Dec 2022
Employees
285.00
CEO
Leonard L. Mazur
Description
Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
CTOR Financial Timeline
Browse a chronological timeline of Citius Oncology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 Aug 2026
EPS estimate is -$0.04, while revenue estimate is $5.83m.
Earnings released on 15 May 2026
EPS came in at -$0.27 falling short of the estimated -$0.01 by -2.60k%, while revenue for the quarter reached $1.67m , missing expectations by -76.17%.
Earnings released on 13 Feb 2026
EPS came in at -$0.06 falling short of the estimated -$0.04 by -50.00%, while revenue for the quarter reached $3.94m , missing expectations by -9.81%.
Earnings released on 23 Dec 2025
EPS came in at -$0.06 matching the estimated -$0.06.
Earnings released on 12 Aug 2025
EPS came in at -$0.08 surpassing the estimated -$0.15 by +46.67%.
Earnings released on 14 May 2025
EPS came in at -$0.11 falling short of the estimated -$0.09 by -22.22%.
Earnings released on 14 Feb 2025
EPS came in at -$0.09 falling short of the estimated -$0.06 by -50.00%.
Earnings released on 27 Dec 2024
EPS came in at -$0.07 surpassing the estimated -$0.08 by +10.33%.
Earnings released on 31 Mar 2024
EPS came in at $0.01 .
Earnings released on 31 Dec 2023
EPS came in at -$0.05 .
Earnings released on 30 Sept 2023
EPS came in at $0.00 .
Earnings released on 30 Jun 2023
EPS came in at $0.07 .
Earnings released on 31 Mar 2023
EPS came in at $0.07 .
Earnings released on 31 Dec 2022
EPS came in at $0.04 .
Earnings released on 30 Sept 2022
EPS came in at -$0.00 .
Earnings released on 30 Jun 2022
EPS came in at -$0.00 .
CTOR Stock Performance
Access detailed CTOR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
